Volume 52 | Number 3 | June 2017

Abstract List

Pamela Roberto M.P.P., Nicole Brandt Pharm.D., Eberechukwu Onukwugha Ph.D., M.S., Bruce Stuart Ph.D.


Objective

To assess the impact of substance abuse claims redaction on Medicare spending estimates for beneficiaries with serious mental illness.


Data Sources

The 2012 claims and unredacted beneficiary‐level Medicare spending totals from 's Chronic Conditions Warehouse.


Study Design

We identified beneficiaries with claims affected by the redaction by comparing claims‐based spending estimates to unredacted spending totals. Differences in characteristics of beneficiaries with and without redacted claims were examined in bivariate analyses.


Principal Findings

Claims‐based spending totals differed from unredacted totals for 19.7 percent of the cohort. Part A spending for those with redacted claims was underreported by 57.0 percent. Characteristics of beneficiaries with and without redacted claims differed significantly.


Conclusions

Researchers who rely on Medicare claims to analyze spending outcomes for beneficiaries with serious mental illness should be aware of the potential for bias due to nonrandom redaction of substance abuse data.